RISTOVA® Injection (Rituximab )



RISTOVA® (Rituximab) is a monoclonal antibody indicated for B cell Non-Hodgkin’s Lymphoma and chronic lymphocytic leukaemia. Apart from haematological malignancies rituximab is also approved for patients with rheumatoid arthritis who have been treated with tumour necrosis factor antagonists, granulomatosis with polyangiitis and microscopic polyangiitis and to treat moderate to severe pemphigus vulgaris.

Click here to view the complete prescribing information.